With over a quarter century of experience and know-how, BioSpring delivers innovative, high-quality oligonucleotide manufacturing and analytical solutions spanning the entire drug development process, from discovery to commercial use. From as small as nmol production for R&D programs to hundreds of kilograms for clinical programs and beyond, BioSpring accommodates all scales to meet you at your program's stage.

We are driven to move your oligonucleotide therapy to clinical and commercial readiness.

BioSpring has been GMP-certified for the manufacture and analysis of therapeutic nucleic acids since 2007 and FDA-inspected, making us one of the most tenured CDMOs in the field. Rely on our commercial experience and analytical expertise to support you through all regulatory filings, upholding the strictest compliance so you can hit your targets.

From small-scale production for R&D to hundreds of kilograms for therapeutic use, from industry-leading analytical expertise to cutting-edge processes, BioSpring covers all your needs for nucleic acid manufacturing.

BioSpring is FDA-inspected and has been cGMP-certified for the manufacture and analysis of therapeutic nucleic acids since 2007, making us one of the most tenured CDMOs in the field. Rely on our commercial experience and analytical expertise to support you through all regulatory filings, upholding the strictest compliance so you can hit your targets.